Has the pregnancy outcome of women with pregestational diabetes mellitus improved in ten years?

Czech version

Authors: Sylvie Dusilová Sulková
Authors‘ workplace: Hemodialyzační středisko FN Hradec Králové, vedoucí lékařka prof. MUDr. Sylvie Dusilová Sulková, DrSc., MBA
Published in: Vnitř Lék 2015; 61(2): 97-100
Category: Editorial

Sources

1. Galperin TA, Cronin AJ, Leslie KS. Cutaneous manifestations of ESRD. Clin J Am Soc Nephrol 2014; 9(1): 201–218.

2. Sprague SM. Painful skin ulcers in a hemodialysis patient. Clin J Am Soc Nephrol 2014; 9(1): 166–173.

3. Sowers KM, Hayden MR Calcific uremic arteriolopathy. Oxidative Medicine and Cellular Longevity 2010; 3(2): 109–121.

4. Sulkova S, Válek M. Skin wounds associated with calciphylaxis in end-stage renal disease patients on dialysis. Nutrition 2010; 26(9): 910–914.

5. Ross EA. Evolution of treatment strategies for calciphylaxis. Am J Nephrol 2011; 34(5): 460–467.

6. Hanvesakul R, Silva MA, Hejmadi R et al. Calciphylaxis following kidney transplantation: a case report. J Med Case Reports 2009; 3: 92–97. Dostupné z DOI: <http://doi: 10.1186/1752–1947–3-9297>.

7. Bishop J, Brown E, Podesta A et al. Surgical management of calciphylaxis associated with primary hyperparathyroidism: a case report and review of the literature. Int J Endocrin 2010; pii: 823210. Dostupné z DOI: <http://doi: 10.1155/2010/823210>.

8. Nigwekar SU, Wolf M, Sterns RH et al. Calciphylaxis from nonuremic causes: a systemic review. Clin J Am Soc Nephrol 2008; 3(4): 1139–1143.

9. Goel SK, Bellowich K, McCullough PA. Treatment of severe metastatic calcification and calciphylasis in dialysis patients. Int J Nephrol 2011; 2011:701603. Dostupné z DOI: <http://doi:10.4061/2011/701603>.

10. Wilmer WA, Magro CM. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial 2002; 15(3): 172–186.

11. Girotto JA, Harmon JW, Ratner LE et al. Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidism. Surgery 2001; 130(4): 645–650.

12. Duffy A, Schurr M, Warner T et al. Long-term outcomes in patients with calciphylaxis from hyperparathyroidism. Ann Surg Oncol 2006; 13(1): 96–102.

13. Weenig R, Sewell LD, Davis MDP et al. Calciphylaxis: natural history, risk factor analysis and outcome. J Am Acad Dermatol 2007; 56(4): 569–579.

14. Schlieper G, Brandengurg V, Ketteler M et al. Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat Rev Nephrol 2009; 5(9): 539–543.

15. Rogers NM, Coates PT. Calcific uraemic arteriolopathy: an update. Curr Opin Nephrol Hypertens 2008; 17(6): 629–634.

16. Farah M, Crawford MR, Levin A et al. Calciphylaxis in the current era: emerging „ironic“ feature? Nephrol Dial Transplant 2011; 26(1): 191–195.

17. Brandengurg VM, Cozzolino M, Mazzaferro S. Calcific uremic arteriolopathy: A call for action. Semin Nephrol 2014; 34(6): 641–647.

18. Pujar T, Spinello EM. A 44year-old lady with chronic renal disease and intractable ulcers: a case report. Int Archives of Medicine, 2009; 2(1): 22.